Clinical Trials in Boston

Showing 7441-7460 of 17,836 trials

HEALEY ALS Platform Trial - Regimen D Pridopidine

NCT04615923

The HEALEY ALS Platform Trial is a perpetual multi-center, multi-regimen clinical trial evaluating the safety and efficacy of investigational products for the treatment of ALS. Regimen D will evaluate the safety and efficacy of a single study drug, pridopidine, in participants with ALS.

Amyotrophic Lateral Sclerosis

Merit E. Cudkowicz, MD163 participantsStarted Dec 2020

Boston, Massachusetts, United States

COMPLETEDPhase 3< 1 mile

Safety and Tolerability of Repeat Courses of IM Alefacept

NCT00233662

The purpose of this study is to determine whether repeat courses of alefacept, administered intramuscularly, are safe when given to chronic plaque psoriasis patients who are receiving standard dermatology treatments.

Chronic Plaque Psoriasis

Biogen400 participantsStarted Dec 2002

Irvine, California, United States • San Francisco, California, United States • Santa Monica, California, United States +43 more locations

HEALEY ALS Platform Trial - Regimen D Pridopidine

Safety and Tolerability of Repeat Courses of IM Alefacept

Find Trials by Condition in Boston

A Study to Evaluate the Safety of bb2121 in Subjects With High Risk, Newly Diagnosed Multiple Myeloma (NDMM)

Efficacy and Safety of the Combination Therapy of Dabrafenib and Trametinib in Subjects With BRAF V600E- Mutated Rare Cancers

Effects of Mitigation Treatments on Bruising of CCH-aaes Treatment of Buttock Cellulite

Nivolumab, Ixazomib, Cyclophosphamide, and Dexamethasone in Relapsed/Refractory Myeloma

A Retrospective, Observational, Non-interventional Trial to Assess Eculizumab Treatment Effect in Patients With Atypical Hemolytic Uremic Syndrome (aHUS)

Nano-Pulse Stimulation (NPS) in Seborrheic Keratosis Study

An Efficacy, Safety, and Tolerability Study Comparing Dolutegravir Plus Lamivudine With Dolutegravir Plus Tenofovir/Emtricitabine in Treatment naïve HIV Infected Subjects (Gemini 1)

Setmelanotide Phase 2 Treatment Trial in Participants With Rare Genetic Disorders of Obesity

BioVentrix Revivent TC™ System Clinical Study

Alternative Dosing of Exemestane Before Surgery in Treating Postmenopausal Patients With Stage 0-II Estrogen Positive Breast Cancer

Nab-Paclitaxel to Paclitaxel in Advanced Urothelial Cancer Progressing on or After Platinum Containing Regimen.

Radiation Therapy in Treating Women Who Have Undergone Surgery for Early-Stage Invasive Breast Cancer

A Study Evaluating Venetoclax (ABT-199) in Multiple Myeloma Subjects Who Are Receiving Bortezomib and Dexamethasone as Standard Therapy

Phase II Study of Interleukin-21 (rIL-21) vs Dacarbazine (DTIC) in Patients With Metastatic or Recurrent Melanoma

TVT-SECUR A Pilot Study for the Treatment of Stress Urinary Incontinence

M7824 in Combination With Chemotherapy in Stage IV Non-small Cell Lung Cancer (NSCLC)

A Study of PX-866 in Patients With Glioblastoma Multiforme at Time of First Relapse or Progression

BMS-986325 in Healthy Participants and Participants With Primary Sjögren's Syndrome